Gene9701
PPP6R2: protein phosphatase 6 regulatory subunit 2
Cite this record
ConductScience Library. PPP6R2: protein phosphatase 6 regulatory subunit 2. Genes, record 9701. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/9701
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O75170 | Serine/threonine-protein phosphatase 6 regulatory subunit 2 | 966 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents36
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260337666 A1 | 2026-10-29 | 33994 | O75170 | Espacenet |
| US 20260193644 A1 | 2026-07-09 | 231 | O75170 | Espacenet |
| US 12577609 B2 | 2026-03-17 | 33994 | O75170 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 231 | O75170 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 231 | O75170 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 33994 | O75170 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 2885 | O75170 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 33994 | O75170 | Espacenet |
| US 20240285795 A1 | 2024-08-29 | 324378 | O75170 | Espacenet |
| US 20240131193 A1 | 2024-04-25 | 4702 | O75170 | Espacenet |
NIH grants196
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PPP6R2 papers | Newest fiscal year |
|---|---|---|---|
| R35GM119455 | Mechanisms of Phosphorylation Signaling by Phosphoprotein Phosphatases | 7 | 2025 |
| P20GM113132 | The Institute for Biomolecular Targeting | 3 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 3 | 2025 |
| P30CA023108 | Cancer Center Support Grant | 3 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 2 | 2025 |
| T32CA009109 | Cancer Research Training Program: From Molecular Mechanisms to Therapeutic Strategies | 2 | 2025 |
| DP1DA054373 | Identifying specific genetic pathway interactions for drug use and abuse through integrative omics | 1 | 2025 |
| K12GM081266 | The UCSF IRACDA Scholars Program. | 1 | 2025 |
| P01AG019724 | Frontotemporal Dementia: Genes, Images, and Emotions | 1 | 2025 |
| P01CA019014 | Viral Oncogenesis, Latency, and Replication | 1 | 2025 |
Source NIH's project files
Papers332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Outcomes of a bedside ultrasound-guided peripherally-inserted central catheter placement across critically-ill older patients. | PLoS One | 2026 | 41860933 | PubTator, text mining | PubMed |
| Clinical Outcomes of Critically Ill Patients with Candida spp. Peritonitis: A Retrospective Cohort Study. | J Fungi (Basel) | 2025 | 40863513 | PubTator, text mining | PubMed |
| Interactome Analysis of the CC2D1A Scaffold Reveals Novel Neuronal Interactions and a Postsynaptic Role. | bioRxiv | 2025 | 40667103 | PubTator, text mining | PubMed |
| Dephosphorylation-related signature predicts the prognosis of papillary renal cell carcinoma. | Transl Cancer Res | 2024 | 39697703 | PubTator, text mining | PubMed |
| Network Pharmacology Approaches Used to Identify Therapeutic Molecules for Chronic Venous Disease Based on Potential miRNA Biomarkers. | J Xenobiot | 2024 | 39449424 | PubTator, text mining | PubMed |
| Therapeutic impact of basic critical care echocardiography performed by residents after limited training. | Ann Intensive Care | 2024 | 39073505 | PubTator, text mining | PubMed |
| Protein phosphatase 6 promotes stemness of colorectal cancer cells. | Cancer Sci | 2024 | 39014521 | PubTator, text mining | PubMed |
| Wean early leave early: Apt strategy for weaning from non-invasive ventilation. | Lung India | 2024 | 38953192 | PubTator, text mining | PubMed |
| The protein phosphatase PP6 promotes RIPK1-dependent PANoptosis. | BMC Biol | 2024 | 38807188 | PubTator, text mining | PubMed |
| Novel Variants Linked to the Prodromal Stage of Parkinson's Disease (PD) Patients. | Diagnostics (Basel) | 2024 | 38732343 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9701
GET https://conductscience.org/api/genes/v1/9701/patents?page=2